Temesta and aspartate aminotransferase increased Patient Reports February 12, 2012

Temesta Side Effects Report #4696116-5
Temesta side effect was reported by a Physician from on June 02, 2005. Female patient, 42 years of age, weighting 178.6 lb, was treated with Temesta. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, glutamate dehydrogenase increased. Temesta dosage: 0.5 MG Q DAY. During the same period patient was treated with SEROQUEL. Patient recovered.

Temesta Side Effects Report #4696109-8
Temesta side effect was reported by a Physician from on June 03, 2005. Male patient, 32 years of age, was treated with Temesta. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood potassium decreased, extrapyramidal disorder, muscle spasms, nasopharyngeal disorder, tongue disorder. Temesta dosage: 5 MG Q DAY PO. During the same period patient was treated with ABILIFY, TRITTICO. Patient was hospitalized. Patient recovered.

Temesta Side Effects Report #5403529-2
Temesta side effect was reported by a Health Professional from SWITZERLAND on July 13, 2007. Male patient was treated with Temesta. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, altered state of consciousness, aspartate aminotransferase increased, cyanosis, diabetic ketoacidosis, hyperglycaemia, pneumonia , renal failure acute, respiratory depression. Temesta dosage: 2.5 MG TID, ORAL. During the same period patient was treated with DORMICUM, STILNOX, TRANXILIUM, SORTIS, ACETAMINOPHEN, NORVASC, BELOC, TOREM. Patient was hospitalized. Patient died on 05/06/2007.

Temesta Side Effects Report #6081769-X
Temesta side effect was reported by a Physician from SWITZERLAND on Feb 03, 2009. Male patient was treated with Temesta. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase decreased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood lactate dehydrogenase increased, conduct disorder, confusional state, disturbance in attention. Temesta dosage: (4 MG QD ORAL). During the same period patient was treated with ZYPREXA. Patient was hospitalized. Patient recovered.